|
Variables
|
n
|
Median survival (95% CI) (days)
|
P
|
|---|
|
Age (years)
| | | |
|
<60
|
27
|
370.0 (301.3-438.7)
|
0.665
|
|
≥ 60
|
15
|
333.0 (244.6-421.4)
| |
|
Stage
| | | |
|
III
|
23
|
416.0 (369.1-462.8)
|
0.163
|
|
IV
|
19
|
327. 0 (298.7-355.3)
| |
|
T factor
| | | |
|
T2-T3
|
17
|
431.0 (315.3-546.7)
|
0.051
|
|
T4
|
25
|
348.0 (248.3-447.6)
| |
|
N factor
| | | |
|
N0-N1
|
21
|
394.0 (312.2-475.8)
|
0.380
|
|
N2-N3
|
21
|
348.0 (310.1-385.9)
| |
|
ECOG
| | | |
|
1
|
30
|
403.0 (327.9-478.0)
|
0.130
|
|
2-3
|
12
|
333.0 (311.5-354.5)
| |
|
Histology
| | | |
|
SCC
|
31
|
367.0 (288.1-445.9)
|
0.270
|
|
ADC
|
11
|
394.0 (324.8-463.1)
| |
|
Smoking habit
| | | |
|
Smokers
|
36
|
370.0 (294.0-446.0)
|
0.745
|
|
Non-smokers
|
06
|
367.0 (248.7-485.3)
| |
|
Tobacco habit
| | | |
|
Yes
|
08
|
394.0 (352.3-435.6)
|
0.022
|
|
No
|
34
|
314.0 (266.0-362.0)
| |
|
Plasma VEGF (median)
| | | |
|
<275.2 pg/mL
|
21
|
348.0 (246.1-449.9)
|
0.885
|
|
≥ 275.2 pg/mL
|
21
|
370.0 (288.3-451.7)
| |
- T, tumor; N, nodal status; ECOG, Eastern Cooperative Oncology Group; VEGF, vascular endothelial growth factor; 95% CI, 95% confidence interval.
